BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1684016)

  • 1. All-trans retinoic acid in myelogenous leukaemia.
    Gallagher RE; Wiernik PH
    Lancet; 1991 Dec 21-28; 338(8782-8783):1603. PubMed ID: 1684016
    [No Abstract]   [Full Text] [Related]  

  • 2. Retinoid resistance.
    Warrell RP
    Lancet; 1993 Jan; 341(8837):126. PubMed ID: 8093401
    [No Abstract]   [Full Text] [Related]  

  • 3. Modulation of all-trans retinoid acid pharmacokinetics in acute promyelocytic leukaemia by prolonged interferon-alpha therapy.
    Lazzarino M; Corso A; Regazzi MB; Iacona I; Bernasconi C
    Br J Haematol; 1995 Aug; 90(4):928-30. PubMed ID: 7669674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary treatment of acute promyelocytic leukemia using all-trans-retinoic acid].
    Leeksma OC; van Oers MH; van der Schoot CE; Goudsmit R; von dem Borne AE
    Ned Tijdschr Geneeskd; 1993 Apr; 137(16):821-5. PubMed ID: 8487886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo evidence of all-trans retinoic acid inducing maturation in acute promyelocytic leukaemia.
    Hamidah HN; Cheong SK; Ainoon O
    Acta Haematol; 1993; 89(1):50-1. PubMed ID: 8480488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All trans-retinoic acid in the treatment of promyelocytic leukaemia--a case report.
    Hoe TS; Cheong SK; Hussin NH; Chum KW
    Med J Malaysia; 1992 Sep; 47(3):225-7. PubMed ID: 1491649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute promyelocytic leukaemia. Report of a meeting of Physicians and Scientists, University College London.
    Lancet; 1994 Dec; 344(8937):1615-8. PubMed ID: 7983997
    [No Abstract]   [Full Text] [Related]  

  • 8. Restoration of all-trans retinoic acid sensitivity by interferon in acute promyelocytic leukaemia.
    Koller E; Krieger O; Kasparu H; Lutz D
    Lancet; 1991 Nov; 338(8775):1154-5. PubMed ID: 1682582
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term survival of acute promyelocytic leukaemia patients treated with arsenic and retinoic acid.
    Zhu HH; Wu DP; Jin J; Li JY; Ma J; Wang JX; Chen SJ; Huang XJ
    Br J Haematol; 2016 Sep; 174(5):820-2. PubMed ID: 27545413
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of acute promyelocytic leukemia with all-trans retinoic acid: successful control of hyperleukocytosis and leukostasis syndrome with leukaphereses and hydroxyurea.
    Hwang WL; Gau JP; Chen MC; Young JH
    Am J Hematol; 1993 Aug; 43(4):323-4. PubMed ID: 8372818
    [No Abstract]   [Full Text] [Related]  

  • 11. Meningeal relapse in a patient with acute promyelocytic leukaemia treated with all-trans retinoic acid.
    Martino B; Vincelli I; Marino A; Comis M; Ronco F; Nobile F
    Br J Haematol; 1998 Mar; 100(3):606-7. PubMed ID: 9504652
    [No Abstract]   [Full Text] [Related]  

  • 12. Pseudotumour cerebri occurring before treatment of acute promyelocytic leukaemia with all-trans-retinoic acid (ATRA).
    Knox-Macaulay HH; Hiwase D; Nusrat N; Ganesh A
    Haematologia (Budap); 2002; 32(1):81-5. PubMed ID: 12243560
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of first relapse in acute promyelocytic leukaemia with all-trans retinoic acid.
    Degos L; Chomienne C; Daniel MT; Berger R; Dombret H; Fenaux P; Castaigne S
    Lancet; 1990 Dec; 336(8728):1440-1. PubMed ID: 1978887
    [No Abstract]   [Full Text] [Related]  

  • 14. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
    Warrell RP; Frankel SR; Miller WH; Scheinberg DA; Itri LM; Hittelman WN; Vyas R; Andreeff M; Tafuri A; Jakubowski A
    N Engl J Med; 1991 May; 324(20):1385-93. PubMed ID: 1850498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All trans retinoic acid in acute promyelocytic leukemia.
    Degos L; Castaigne S; Fenaux P; Daniel MT; Dombret H; Chomienne C
    Nouv Rev Fr Hematol (1978); 1991; 33(2):183-5. PubMed ID: 1766850
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone marrow necrosis following ALL-trans retinoic acid therapy for acute promyelocytic leukaemia.
    Dreosti LM; Bezwoda W; Gunter K
    Leuk Lymphoma; 1994 Apr; 13(3-4):353-6. PubMed ID: 8049655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-trans retinoic acid in the treatment of acute promyelocytic leukaemia.
    White KL; Wiley JS; Frost T; McKendrick JJ; Hermann RP; Seldon M; Enno A; Bell R; Bunce I; Taylor K
    Aust N Z J Med; 1992 Oct; 22(5):449-54. PubMed ID: 1445034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute promyelocytic leukemia in pregnancy: all-trans retinoic acid as a newer therapeutic option.
    Celo JS; Kim HC; Houlihan C; Canavan BF; Manzullo GP; Saidi P
    Obstet Gynecol; 1994 May; 83(5 Pt 2):808-11. PubMed ID: 8159357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudotumour cerebri as a manageable side effect of prolonged all-trans retinoic acid therapy in an adult patient with acute promyelocytic leukaemia.
    Gallipoli P; Drummond MW
    Eur J Haematol; 2009 Mar; 82(3):242-3. PubMed ID: 19018859
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful treatment of acute promyelocytic leukemia in a pregnant Jehovah's Witness with all-trans retinoic acid, rhG-CSF, and erythropoietin.
    Lin CP; Huang MJ; Liu HJ; Chang IY; Tsai CH
    Am J Hematol; 1996 Mar; 51(3):251-2. PubMed ID: 8619417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.